盛禾生物控股有限公司（股票代码：02898）于2026年7月6日发布2026年6月股份变动月报表。根据公告，截至2026年6月30日，该公司注册股本与已发行股份数均无变动。
本月报显示，法定/注册股本数额为2亿股普通股，面值为每股USD 0.0005，总额USD 100,000；报告期内未新增及未减少注册股本，月末保持不变。此外，截至6月底，盛禾生物-B已发行股份数量为156,666,800股，与上月底结余相同，未有购回、注销或库藏股变动。
公告同时称，该公司已满足香港联交所对上市公司公众持股量的要求。各项涉及股份激励、配股及其他潜在股份发行工具在本报告期内同样未发生变动。
本次月报由公司主席兼执行董事张峰签署。盛禾生物-B确认继续遵守香港联交所《上市规则》及其他相关法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.